BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33762162)

  • 1. Suppressing long noncoding RNA OGRU ameliorates diabetic retinopathy by inhibition of oxidative stress and inflammation via miR-320/USP14 axis.
    Fu S; Zheng Y; Sun Y; Lai M; Qiu J; Gui F; Zeng Q; Liu F
    Free Radic Biol Med; 2021 Jun; 169():361-381. PubMed ID: 33762162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-26a-5p Attenuates Oxidative Stress and Inflammation in Diabetic Retinopathy through the USP14/NF-
    Bian J; Ge W; Jiang Z
    J Ophthalmol; 2024; 2024():1470898. PubMed ID: 38282961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways.
    Shao K; Xi L; Cang Z; Chen C; Huang S
    J Cell Physiol; 2020 Dec; 235(12):9361-9369. PubMed ID: 32356340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis.
    Luo R; Li L; Xiao F; Fu J
    Inflammation; 2022 Oct; 45(5):1936-1949. PubMed ID: 35461393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA TPTEP1 suppresses diabetic retinopathy by reducing oxidative stress and targeting the miR-489-3p/NRF2 axis.
    Wang X; Zhou X; Wang F; Zhang N; Zhang Y; Ao Z; He F
    Acta Biochim Pol; 2023 Feb; 70(1):45-50. PubMed ID: 36795778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2.
    Tian M; Yang J; Yan X; Cao Y; Liu Y; Lei Y; Lv H
    Bioengineered; 2022 May; 13(5):12661-12672. PubMed ID: 35599572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy.
    Shen Y; Tong ZW; Zhou Y; Sun Y; Xie Y; Li R; Liu H
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6864-6872. PubMed ID: 32633379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.
    Li W; Jin L; Cui Y; Nie A; Xie N; Liang G
    J Endocrinol Invest; 2021 Jun; 44(6):1193-1207. PubMed ID: 32979189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA XIST restrains the activation of Müller cells and inflammation in diabetic retinopathy via stabilizing SIRT1.
    Zhang J; Chen C; Zhang S; Chen J; Wu L; Chen Z
    Autoimmunity; 2021 Dec; 54(8):504-513. PubMed ID: 34498499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
    Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
    Liu X; Li J; Li X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-MYC-activated lncRNA SNHG20 accelerates the proliferation of diffuse large B cell lymphoma via USP14-mediated deubiquitination of β-catenin.
    Wang C; Fu W; Zhang Y; Hu X; Xu Q; Tong X
    Biol Direct; 2024 Jun; 19(1):47. PubMed ID: 38886753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0000615 promotes high glucose-induced human retinal pigment epithelium cell apoptosis, inflammation and oxidative stress via miR-646/YAP1 axis in diabetic retinopathy.
    Zeng Q; Luo Y; Fang J; Xu S; Hu YH; Yin M
    Eur J Ophthalmol; 2022 May; 32(3):1584-1595. PubMed ID: 34096368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
    Wang JJ; Wu KF; Wang DD
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis.
    Ke N; Pi LH; Liu Q; Chen L
    Biochem Biophys Res Commun; 2019 Jun; 514(2):503-509. PubMed ID: 31056258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP14 Regulates ATF2/PIK3CD Axis to Promote Microvascular Endothelial Cell Proliferation, Migration, and Angiogenesis in Diabetic Retinopathy.
    He FT; Fu XL; Li MH; Fu CY; Chen JZ
    Biochem Genet; 2023 Oct; 61(5):2076-2091. PubMed ID: 36939972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis.
    Tong P; Peng QH; Gu LM; Xie WW; Li WJ
    Exp Mol Pathol; 2019 Apr; 107():102-109. PubMed ID: 30529346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.
    Lang Y; Zhang H; Yu H; Li Y; Liu X; Li M
    Bioengineered; 2022 Jan; 13(1):930-940. PubMed ID: 34967706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing
    Zhang J; Chen M; Chen J; Lin S; Cai D; Chen C; Chen Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.